Cargando…
MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis
INTRODUCTION: Eosinophilic esophagitis (EoE) is a clinico-pathological diagnosis characterized by esophageal dysfunction and eosinophilic infiltration of the esophagus. Demonstration of esophageal eosinophilia (more than 15 eosinophils/hpf) in biopsy specimen obtained by esophagogastroduodenoscopy (...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457706/ https://www.ncbi.nlm.nih.gov/pubmed/32923026 http://dx.doi.org/10.1177/2152656720953378 |
_version_ | 1783576050516623360 |
---|---|
author | Bhardwaj, Neeti Sena, Maria Ghaffari, Gisoo Ishmael, Faoud |
author_facet | Bhardwaj, Neeti Sena, Maria Ghaffari, Gisoo Ishmael, Faoud |
author_sort | Bhardwaj, Neeti |
collection | PubMed |
description | INTRODUCTION: Eosinophilic esophagitis (EoE) is a clinico-pathological diagnosis characterized by esophageal dysfunction and eosinophilic infiltration of the esophagus. Demonstration of esophageal eosinophilia (more than 15 eosinophils/hpf) in biopsy specimen obtained by esophagogastroduodenoscopy (EGD) continues to be the gold standard for diagnosis and monitoring of response to therapy. There is a growing necessity for non-invasive biomarkers that can accurately diagnose this condition and assess response to therapy. While microRNAs (miRNA) are being investigated in allergic diseases, including EoE, not many studies have explored the role of salivary miRNAs in EoE. MiR-4668-5p is a particularly interesting candidate, as it is predicted to regulate TGF-beta signaling and has not previously been identified as a target in any allergy disease. We sought to further investigate the role of miR-4668 as a biomarker to characterize and monitor response to treatment with swallowed topical glucocorticoids. METHODS: After IRB approval, twenty-two adult patients with EoE were randomly enrolled to provide a saliva sample before and after 2 months of swallowed fluticasone therapy. Differences of miRNA expression before and after treatment were analyzed by paired T-test. A significance cutoff of <0.05 was used for all analyses. RESULTS: Expression of miR-4668 was higher in EoE vs. non-EoE subjects. The level of miR-4668 decreased in all subjects except one, with a mean fold change 0.49 ± 0.25. There was an association between miRNA expression and number of positive aeroallergens. The miR-4668 high group had a higher number of positive aeroallergen tests, while the miR-4668 low group had a greater number of subjects with drug allergies. CONCLUSIONS: In this study, we identified that salivary miRNAs may serve as biomarkers to characterize EoE and response to topical corticosteroids. We specifically identified miR-4668 as a novel potential biomarker, which was not previously discovered as a target in EoE or any other allergic disease. |
format | Online Article Text |
id | pubmed-7457706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-74577062020-09-11 MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis Bhardwaj, Neeti Sena, Maria Ghaffari, Gisoo Ishmael, Faoud Allergy Rhinol (Providence) Original Research INTRODUCTION: Eosinophilic esophagitis (EoE) is a clinico-pathological diagnosis characterized by esophageal dysfunction and eosinophilic infiltration of the esophagus. Demonstration of esophageal eosinophilia (more than 15 eosinophils/hpf) in biopsy specimen obtained by esophagogastroduodenoscopy (EGD) continues to be the gold standard for diagnosis and monitoring of response to therapy. There is a growing necessity for non-invasive biomarkers that can accurately diagnose this condition and assess response to therapy. While microRNAs (miRNA) are being investigated in allergic diseases, including EoE, not many studies have explored the role of salivary miRNAs in EoE. MiR-4668-5p is a particularly interesting candidate, as it is predicted to regulate TGF-beta signaling and has not previously been identified as a target in any allergy disease. We sought to further investigate the role of miR-4668 as a biomarker to characterize and monitor response to treatment with swallowed topical glucocorticoids. METHODS: After IRB approval, twenty-two adult patients with EoE were randomly enrolled to provide a saliva sample before and after 2 months of swallowed fluticasone therapy. Differences of miRNA expression before and after treatment were analyzed by paired T-test. A significance cutoff of <0.05 was used for all analyses. RESULTS: Expression of miR-4668 was higher in EoE vs. non-EoE subjects. The level of miR-4668 decreased in all subjects except one, with a mean fold change 0.49 ± 0.25. There was an association between miRNA expression and number of positive aeroallergens. The miR-4668 high group had a higher number of positive aeroallergen tests, while the miR-4668 low group had a greater number of subjects with drug allergies. CONCLUSIONS: In this study, we identified that salivary miRNAs may serve as biomarkers to characterize EoE and response to topical corticosteroids. We specifically identified miR-4668 as a novel potential biomarker, which was not previously discovered as a target in EoE or any other allergic disease. SAGE Publications 2020-08-28 /pmc/articles/PMC7457706/ /pubmed/32923026 http://dx.doi.org/10.1177/2152656720953378 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Bhardwaj, Neeti Sena, Maria Ghaffari, Gisoo Ishmael, Faoud MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis |
title | MiR-4668 as a Novel Potential Biomarker for Eosinophilic
Esophagitis |
title_full | MiR-4668 as a Novel Potential Biomarker for Eosinophilic
Esophagitis |
title_fullStr | MiR-4668 as a Novel Potential Biomarker for Eosinophilic
Esophagitis |
title_full_unstemmed | MiR-4668 as a Novel Potential Biomarker for Eosinophilic
Esophagitis |
title_short | MiR-4668 as a Novel Potential Biomarker for Eosinophilic
Esophagitis |
title_sort | mir-4668 as a novel potential biomarker for eosinophilic
esophagitis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457706/ https://www.ncbi.nlm.nih.gov/pubmed/32923026 http://dx.doi.org/10.1177/2152656720953378 |
work_keys_str_mv | AT bhardwajneeti mir4668asanovelpotentialbiomarkerforeosinophilicesophagitis AT senamaria mir4668asanovelpotentialbiomarkerforeosinophilicesophagitis AT ghaffarigisoo mir4668asanovelpotentialbiomarkerforeosinophilicesophagitis AT ishmaelfaoud mir4668asanovelpotentialbiomarkerforeosinophilicesophagitis |